Tatiana Shkurat

Prof. Tatiana Shkurat

Academy of Biology and Biotechnologies, Southern Federal University, Rostov-on-Don, Russia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V. Sinyov
Vasily V. Sinyov
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
MSMarina D. Sazonova
Marina D. Sazonova
ZKZukhra Khasanova
Zukhra Khasanova
ISIgor Sobenin
Igor Sobenin
In the present work, a pilot creation of four cybrid cultures with high heteroplasmy level was performed using mitochondrial genome mutations m.12315G>A and m.1555G>A. According to data of our preliminary studies, the threshold heteroplasmy level of mutation m.12315G>A is associated with atherosclerosis. At the same time, for a mutation m.1555G>A, such a heteroplasmy level is associated with the absence of atherosclerosis. Cybrid cultures were created by fusion of rho0-cells and mitochondria from platelets with a high heteroplasmy level of the investigated mutations. To create rho0-cells, THP-1 culture of monocytic origin was taken. According to the results of the study, two cybrid cell lines containing mutation m.12315G>A with the heteroplasmy level above the threshold value (25% and 44%, respectively) were obtained. In addition, two cybrid cell lines containing mutation m.1555G>A with a high heteroplasmy level (24%) were obtained. Cybrid cultures with mtDNA mutation m.12315G>A can be used to model both the occurrence and development of atherosclerosis in cells and the titration of drug therapy for patients with atherosclerosis. With the help of cybrid cultures containing single nucleotide replacement of mitochondrial genome m.1555G>A, it is possible to develop approaches to the gene therapy of atherosclerosis.

1 August 2024 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
Donald AdjerohDonald Adjeroh
Donald Adjeroh
XZXiaobo Zhou
Xiaobo Zhou
APAlexandre Paschoal
Alexandre Paschoal
NDNadya Dimitrova
Nadya Dimitrova
EDEkaterina Derevyanchuk
Ekaterina Derevyanchuk
LEONARD LIPOVICHLEONARD LIPOVICH
LEONARD LIPOVICH
This is a mini-review capturing the views and opinions of selected participants at the 2021 IEEE BIBM 3rd Annual LncRNA Workshop, held in Dubai, UAE. The views and opinions are expressed on five broad themes related to problems in lncRNA, namely, challenges in the computational analysis of lncRNAs, lncRNAs and cancer, lncRNAs in sports, lncRNAs and COVID-19, and lncRNAs in human brain activity.

30 March 2023 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
TSTatiana Shkurat
Tatiana Shkurat
MAManar Ammar
Manar Ammar
OBOlga Bocharova
Olga Bocharova
ETElena Teplyakova
Elena Teplyakova
AAAnzhela Aleksandrova
Anzhela Aleksandrova
LEONARD LIPOVICHLEONARD LIPOVICH
LEONARD LIPOVICH
Long non-coding RNAs (lncRNAs) play important roles in the maintenance of metabolic homeostasis. Recently, many studies have suggested that lncRNAs, such as Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) and Imprinted Maternally Expressed Transcript (H19), might participate in the pathogenesis of metabolic disorders such as obesity. We conducted a case-control study with 150 Russian children and adolescents aged between 5 and 17 years old in order to assess the statistical association between the single nucleotide polymorphisms (SNPs) rs3200401 in MALAT1 and rs217727 in H19, and the risk of developing obesity in this population. We further explored the possible association of rs3200401 and rs217727 with BMI Z-score and insulin resistance. The MALAT1 rs3200401 and H19 rs217727 SNPs were genotyped using Taqman SNP genotyping assay. The MALAT1 rs3200401 SNP was identified as a risk factor for childhood obesity (p < 0.05) under the dominant and allelic models, and the CT heterozygous genotype was associated with the risk of increased BMI and with insulin resistance. The H19 rs217727 SNP had no significant association with obesity risk (all p > 0.05). Our findings thus suggest that MALAT1 SNP rs3200401 is a potential indicator of obesity susceptibility and pathogenesis in children and adolescents.

6 December 2023 in Ecological genetics
Verified
Journal Article
Open access
PDF file
MSMikhail A. Shkurat
Mikhail A. Shkurat
EMElena V. Mashkina
Elena V. Mashkina
NMNatalya P. Milyutina
Natalya P. Milyutina
TSTatiana Shkurat
Tatiana Shkurat
МПМилютина Наталья Петровна
Милютина Наталья Петровна
The review summarizes ideas about the role of polymorphic variants of redox-sensitive genes that regulate the development of oxidative stress in obesity and associated metabolic diseases. The concept of oxidative stress, activated oxygen metabolites (AOM), which include reactive forms of oxygen, nitrogen, and chlorine, is considered, and an idea of the antioxidant system and its enzymatic link is given. The important role of gene polymorphism of AOM-producing enzymes — CYBA, CYBB, MT-ND1/2/4L, MT-CO1/3, XOR, CYP, NOS2/3, MPO — in the induction of oxidative stress in obesity has been shown. The dualism of AOM in obesity is emphasized: on the one hand, they are necessary for normal adipogenesis and signaling, and, on the other hand, they play a trigger role in the development of oxidative stress. It has been demonstrated that an imbalance in antioxidant system in obesity and metabolic disorders may be associated with variability in the genes of key antioxidant enzymes and proteins — SOD1/2/3, CAT, GPX1-8, GSR, GSTP1, GSTM1, GSTT1, PRDX3, TXNIP, HMOX1, NQO1, NFE2L2, KEAP1. The critical role of polymorphism in the Nrf2 transcription factor gene, the main regulator of redox homeostasis under physiological conditions and in obesity, has been demonstrated. It has been demonstrated that disruption of redox homeostasis due to genetic variability of the prooxidant-antioxidant system contributes to the development of the pathological obesity phenotype. Understanding the genetic mechanisms underlying oxidative stress in obesity and metabolic diseases is necessary to expand knowledge about the mechanisms of pathogenesis of these diseases and to develop effective methods for their correction.

1 October 2022 in Baghdad Science Journal
Verified
Journal Article
Open access
PDF file
LVLomteva S V
Lomteva S V
TSTatiana Shkurat
Tatiana Shkurat
BSBugrimova E S
Bugrimova E S
ZSZolotykh O S
Zolotykh O S
AAAlexandrova A A
Alexandrova A A
KVKarantysh G V
Karantysh G V
Polycystic ovary syndrome (PCOS) is the main cause of female infertility. The role of insulin resistance in the development of polycystic ovary is actively discussed here. The study included patients with PCOS without insulin resistance (n = 48) and with insulin resistance (n = 39). The comparison groups were patients with no history of PCOS: a control group without insulin resistance (n = 46) and a group of patients with insulin resistance (n = 45). The following parameters were determined in patients: FSH, LH, TSH, T3f, T4f, PRL, E2, 17-OHd, Pr, AMH, Test total, Testf, DHEAS, DHEASs, SHBG, ACTH, cortisol, IRI, IGF-1, C-peptide, and glucose level. The HOMA-IR index and the LH / FSH ratio and the total / SHBG test were calculated. Correlation analysis was also performed between HOMA IR and indicators of the hormonal profile, IGF-1, and C-peptide.Unidirectional changes in the levels of the following hormones were found in insulin resistance, PCOS and / or insulin resistance relative to control values: estradiol, total testosterone, cortisol, prolactin, AMG, and SHBG. As a result of the correlation analysis, negative relationships were established between the HOMA IR Index and the levels of E2, cortisol and AMH in patients (except for the control group).We assume that the formation of the phenotype of polycystic ovary with a combination of insulin resistance can be formed in patients with insulin resistance as a result of a decrease in the level of estradiol, SHBG and an increase in the content of total testosterone and AMH.

12 April 2022 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
DADema Alset
Dema Alset
IPInna O. Pokudina
Inna O. Pokudina
EBElena Butenko
Elena Butenko
TSTatiana Shkurat
Tatiana Shkurat